TipHub

₹1,390.8

▼ -12.63 -0.90%

As of 28 Jul 2026 · delayed

NSE Listed · Pharmaceuticals

Eris Lifesciences Limited (ERIS)

Volume: 52,640Avg Vol 1W: 58,032Avg Vol 1M: 74,92252W Range:₹1,200₹1,885
NSE BSE www.eris.co.in AI Report
Key Ratios
Checked just now
Market Cap₹19,272 Cr
Current Price₹1,390.8
Previous Close₹1,403.43
High / Low (52w)₹1,885 / ₹1,200
Volume52,640
Avg Vol (1W)58,032
Avg Vol (1M)74,922
Stock P/E67.51
Book Value₹281.78
Dividend Yield0.51%
ROE15.87%
ROA8.79%
Revenue (TTM)—
Revenue Growth44.02%
Profit Margin19.89%
Total Debt₹1,738 Cr
Shares Outstanding14 Cr
Face Value₹1
EPS (TTM)₹20.6
P/B4.94
Debt / Equity0.6
50 DMA₹1,411.15
200 DMA₹1,450.97
Day change-0.90%
Price Chart
₹1,390.8▼ 22.39% · 1Y
₹1817₹127138.4L
2025-07-29
2026-07-28

20-day avg volume: 73K shares

Pros
  • Healthy return on equity of 15.9%.
  • Company is almost debt-free.
Cons
  • Revenue fell 12% YoY.
  • Company is loss-making at the latest annual result.
  • Stock trades at a high P/E of 68.
Quarterly Results
MetricJun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026
Revenue₹720 Cr₹741 Cr₹727 Cr₹705 Cr₹773 Cr₹792 Cr₹807 Cr₹757 Cr
EBITDA₹176 Cr₹189 Cr₹174 Cr₹183 Cr₹209 Cr₹222 Cr₹211 Cr₹206 Cr
Net Profit₹83 Cr₹92 Cr₹84 Cr₹94 Cr₹118 Cr₹120 Cr₹100 Cr₹282 Cr
EPS————————
Profit & Loss (Annual)
MetricSept 2024Dec 2024Mar 2025Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026
Revenue₹437 Cr₹400 Cr₹405 Cr₹2,912 Cr₹579 Cr₹651 Cr₹315 Cr₹277 Cr
EBITDA₹102 Cr₹61 Cr₹94 Cr₹720 Cr₹201 Cr₹281 Cr₹64 Cr₹10 Cr
Net Profit₹28 Cr₹2 Cr₹30 Cr₹352 Cr₹100 Cr₹150 Cr₹3 Cr₹-9 Cr
EPS———25.81————
Balance Sheet
MetricMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Total Assets₹1,460 Cr₹1,554 Cr₹1,552 Cr₹1,835 Cr₹2,272 Cr₹3,667 Cr₹7,040 Cr₹7,033 Cr
Total Liabilities₹574 Cr₹385 Cr₹256 Cr₹258 Cr₹364 Cr₹1,447 Cr₹3,818 Cr₹3,761 Cr
Equity₹886 Cr₹1,169 Cr₹1,296 Cr₹1,576 Cr₹1,908 Cr₹2,221 Cr₹3,222 Cr₹3,272 Cr
Total Debt————————
Cash Flow
MetricMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Operating₹304 Cr₹295 Cr₹323 Cr₹444 Cr₹462 Cr₹369 Cr₹587 Cr₹1,163 Cr
Investing₹-590 Cr₹-5 Cr₹123 Cr₹-323 Cr₹-320 Cr₹-982 Cr₹-1,855 Cr₹-80 Cr
Financing₹363 Cr₹-221 Cr₹-335 Cr₹-82 Cr₹-45 Cr₹688 Cr₹1,380 Cr₹-881 Cr
Free Cash Flow₹304 Cr₹295 Cr₹323 Cr₹444 Cr₹462 Cr₹369 Cr₹587 Cr₹1,163 Cr
Shareholding
Promoter 54.14% Institutions 26.47% Public 19.4%
Efficiency & Working Capital
ROCE13.3%
Interest Coverage3.1
Dividend Payout—
Debtor Days58 d
Inventory Days42 d
Payable Days42 d
Cash Conversion Cycle58 d
Working Capital Days100 d
Shareholding Details

As of 2026-06-30

Promoter54.1%
FII5.8%
DII20.7%
Institutions26.5%
Public19.4%
Promoter Pledge16.9%
No. of Shareholders50,798
Shareholding Pattern

Quarterly — figures in %. Latest 12 quarters.

PeriodSept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Promoters54.9%54.9%54.9%54.9%54.9%54.9%54.8%54.8%54.8%54.8%53.9%54.1%
FIIs13.2%13.1%14.3%14.6%8%8.4%8.4%8.4%7.2%6.9%6.4%5.8%
DIIs14.5%13.9%15.6%16.2%18.6%18.1%18.1%18.2%19.4%20.3%20.4%20.7%
Public17.4%18.1%15.2%14.3%18.5%18.7%18.7%18.6%18.6%18%19.3%19.4%
Promoter Pledge11%11%18.5%18.5%18.5%18.5%18.5%16.9%16.9%16.9%16.9%16.9%
No. of Shareholders42,24546,49651,75344,17646,34653,31450,08752,22559,43854,71351,65650,798
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202503————
Major Shareholders (>1%)
NameCategoryStakeShares
Amit Indubhusan BakshiShareholding of Promoter and Promoter Group42.3%5.87 Cr
Lilac Investments LimitedPublic Shareholding8.6%1.20 Cr
Hdfc Small Cap FundPublic Shareholding8.3%1.15 Cr
Franklin India Small Cap FundPublic Shareholding4.3%59,47,337
Rajendrakumar Rambhai PatelShareholding of Promoter and Promoter Group4.3%59,39,834
Inderjeet Singh NegiShareholding of Promoter and Promoter Group4.3%59,39,833
Kaushal Kamleshkumar ShahShareholding of Promoter and Promoter Group3.2%44,68,833
Hetal Rasiklal ShahPublic Shareholding2.1%29,40,000
Bhikhalal Chimanlal ShahPublic Shareholding1.9%26,80,000
Naishadh Vikram ShahPublic Shareholding1.7%23,06,372
Uti-flexi Cap FundPublic Shareholding1.6%21,95,200
Rakesh ShahPublic Shareholding1.4%19,75,981
Hsbc Mutual Fund - Hsbc Small Cap FundPublic Shareholding1%14,25,613
Sarthak NegiShareholding of Promoter and Promoter Group0%100
Suman NegiShareholding of Promoter and Promoter Group0%0
Sateshwari DeviShareholding of Promoter and Promoter Group0%0
Rajeshwari NegiShareholding of Promoter and Promoter Group0%0
Rekha RawatShareholding of Promoter and Promoter Group0%0
Asha RawatShareholding of Promoter and Promoter Group0%0
Manvendra Singh NegiShareholding of Promoter and Promoter Group0%0
Aditi NegiShareholding of Promoter and Promoter Group0%0
Shiv Chanran Singh RawatShareholding of Promoter and Promoter Group0%0
Rameshwari Devi RawatShareholding of Promoter and Promoter Group0%0
Sandeepa RawatShareholding of Promoter and Promoter Group0%0
Upender Singh RawatShareholding of Promoter and Promoter Group0%0
Promoter Pledges
HolderPledged Shares% of HoldingAs of
Amit Indubhusan Bakshi81,76,47013.9%2026-06-30
Rajendrakumar Rambhai Patel18,82,50031.7%2026-06-30
Inderjeet Singh Negi18,82,50031.7%2026-06-30
Kaushal Kamleshkumar Shah7,00,00015.7%2026-06-30
Board of Directors
NameDesignationYear
Amit Indubhushan BakshiChairman / Executive Director / M D / Promoter2025
Kaushal Kamlesh ShahWTD & Executive Director2025
Inderjeet Singh NegiWTD & Executive Director2025
Krishnakumar VaidyanathanExecutive Director / WTD / Chief Operating Officer2025
Prashant GuptaIndependent Non Exe. Director2025
Rajeev Narotam DalalIndependent Non Exe. Director2025
Kalpana UnadkatIndependent Non Exe. Director2025
Sujesh VasudevanIndependent Non Exe. Director2025
Milind TalegaonkarCompany Sec. & Compli. Officer2025
Vineet VarmaAdditional Director2025
Segments — Product
SegmentRevenueShare
Pharmaceuticals₹0 Cr—
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2025₹1301414
Corporate Actions
TypeDateValueRemark
forthcoming2026-07-29Board Meetings—
dividend2026-05-29₹7.21 (721.0%)Interim
dividend2026-05-29₹7.21 (721%)Interim
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
20252,2640014472,325
20252,04300002,043
2025000123
Insider / Designated-Person Trades

29 recent disclosure(s)

SABYASACHI SHARMADisposal · 2,000
Amit Indubhushan BakshiAcquisition · 11,750
Amit Indubhushan BakshiAcquisition · 2,03,000
Amit Indubhushan BakshiAcquisition · 3,96,262
Amit Indubhushan BakshiAcquisition · 1,65,000
VIJAYA SAMPATHDisposal · 3,400
Substantial Acquisitions (SAST)

10 disclosure(s)

Off Market22/08/2024 · 98,86,882
Off Market22/08/2024 · 98,86,882
Market / Inter-se Transfer22/08/2024 · 98,86,882
Market22/08/2024 · 98,86,882
Market14/05/2024 · 27,21,065
Market03/05/2024 · 28,000
Company Information
Incorporated2007
ChairmanAmit Indubhushan Bakshi
AuditorDeloitte Haskins & Sells LLP
Investor Email[email protected]
🌐 www.eris.co.in ↗

📍 8th Floor Commerce House -IV, Prahladnagar 100 FT Road, Ahmedabad, Gujarat, 380015

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

Log inSign up free

More stocks

EPack Prefab Technologies Ltd.Epigral LimitedEPL LimitedEPW India LimitedEquippp Social Impact Technologies Ltd.Equitas Small Finance Bank Ltd.ESAB India Ltd.ESAF Small Finance Bank LimitedEsconet Technologies Ltd.Escorts Kubota LimitedEssen Speciality Films LimitedEsprit Stones LimitedAll “E” stocks →

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search